These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison table: some FDA-approved drugs for weight management. Med Lett Drugs Ther; 2018 Jun; 60(1548):e98-e100. PubMed ID: 29913464 [No Abstract] [Full Text] [Related]
3. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618 [TBL] [Abstract][Full Text] [Related]
4. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? Tak YJ; Lee SY Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104 [TBL] [Abstract][Full Text] [Related]
5. Current and emerging medications for overweight or obesity in people with comorbidities. Fujioka K Diabetes Obes Metab; 2015 Nov; 17(11):1021-32. PubMed ID: 26040215 [TBL] [Abstract][Full Text] [Related]
6. Past, Present, and Future of Pharmacologic Therapy in Obesity. Rodríguez JE; Campbell KM Prim Care; 2016 Mar; 43(1):61-7, viii. PubMed ID: 26896200 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy for the management of obesity. Patel D Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499 [TBL] [Abstract][Full Text] [Related]
8. Past and present of antiobesity agents: focus on monoamine modulators. Khorassani FE; Misher A; Garris S Am J Health Syst Pharm; 2015 May; 72(9):697-706. PubMed ID: 25873617 [TBL] [Abstract][Full Text] [Related]
9. Current and emerging pharmacotherapies for obesity in Australia. Hocking S; Dear A; Cowley MA Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of obesity: Available medications and drugs under investigation. Pilitsi E; Farr OM; Polyzos SA; Perakakis N; Nolen-Doerr E; Papathanasiou AE; Mantzoros CS Metabolism; 2019 Mar; 92():170-192. PubMed ID: 30391259 [TBL] [Abstract][Full Text] [Related]
11. Obesity: The New Global Epidemic Pharmacological Treatment, Opportunities and Limits for Personalized Therapy. Milano W; De Biasio V; Di Munzio W; Foggia G; Capasso A Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1232-1243. PubMed ID: 32410565 [TBL] [Abstract][Full Text] [Related]
14. Drug treatment of obesity: current status and future prospects. Kakkar AK; Dahiya N Eur J Intern Med; 2015 Mar; 26(2):89-94. PubMed ID: 25634851 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy for obesity in individuals with type 2 diabetes. Chukir T; Shukla AP; Saunders KH; Aronne LJ Expert Opin Pharmacother; 2018 Feb; 19(3):223-231. PubMed ID: 29376439 [TBL] [Abstract][Full Text] [Related]
16. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Nuffer W; Trujillo JM; Megyeri J Ann Pharmacother; 2016 May; 50(5):376-88. PubMed ID: 26887340 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Antiobesity Treatment and Weight-Inducing Antihyperglycemic Agents Among Patients With Type 2 Diabetes in the United States. Levin A; Kaur N; Mainoo NK; Perez A Clin Ther; 2022 Mar; 44(3):e35-e44. PubMed ID: 35105470 [TBL] [Abstract][Full Text] [Related]